Total Funding
63
45
Total FundingGrant raised
Growth Score 63 in past quarter
-15 pts
Heat Score 45 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
128028
Soricimed Biopharma operates as a clinical-stage drug and diagnostic development company.
- John (Jack) M. Stewart: Founder, Chief Scientific Officer
- Frank Michalargias: Chief Financial OfficerPast Role: Helix BioPharma, CFO
About the Company
Soricimed is a clinical-stage company with a focus on the development of targeted treatments for cancer. It specializes in developing delivery peptides and therapeutics for several types of solid tumor cancers.